AAAAAA

   
Results: 1-2 |
Results: 2
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
Authors: Milpied, N Vasseur, B Parquet, N Garnier, JL Antoine, C Quartier, P Carret, AS Bouscary, D Faye, A Bourbigot, B Reguerre, Y Stoppa, AM Bourquard, P de Ligny, BH Dubief, F Mathieu-Boue, A Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids
Authors: Lebranchu, Y Aubert, P Bayle, F Bedrossian, J Berthoux, F Bourbigot, B Buchler, M Chalopin, JM Deteix, P Glotz, D De Ligny, BH Kessler, M Lang, P Lefrancois, N Le Pogamp, P Moulin, B Mourad, G Olmer, M Sraer, JD Touchard, G Toupance, O Wolf, P Puget, S
Citation: Y. Lebranchu et al., Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids, TRANSPLAN P, 32(2), 2000, pp. 396-397
Risultati: 1-2 |